Aflibercept-related sterile inflammation.

Severe Ocular Inflammation Following Ranibizumab or Aflibercept Injections for Age-Related Macular Degeneration: A Retrospective Claims Database Analysis. Ophthalmic Epidemiol (2016) 1.39

Ziv-aflibercept in macular disease. Br J Ophthalmol (2015) 1.37

Vitreous inflammation associated with intravitreal anti-VEGF pharmacotherapy. Mediators Inflamm (2013) 0.89

Delayed onset panuveitis following intravitreal aflibercept injection. BMJ Case Rep (2014) 0.78

Sterile Inflammation after Intravitreal Injection of Aflibercept in a Korean Population. Korean J Ophthalmol (2015) 0.78

Bilateral Severe Sterile Inflammation with Hypopyon after Simultaneous Intravitreal Triamcinolone Acetonide and Aflibercept Injection in a Patient with Bilateral Marked Rubeosis Associated with Ocular Ischemic Syndrome. Case Rep Ophthalmol Med (2017) 0.75

An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration. Am J Ophthalmol (2007) 8.12

A variable-dosing regimen with intravitreal ranibizumab for neovascular age-related macular degeneration: year 2 of the PrONTO Study. Am J Ophthalmol (2009) 5.41

Short-term safety and efficacy of intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration. Retina (2006) 3.48

Endophthalmitis associated with intravitreal injections: office-based setting and operating room setting. Retina (2014) 3.41

Evolving guidelines for intravitreous injections. Retina (2004) 3.39

Dynamics of human foveal development after premature birth. Ophthalmology (2011) 3.11

Endophthalmitis isolates and antibiotic sensitivities: a 6-year review of culture-proven cases. Am J Ophthalmol (2004) 2.98

Endophthalmitis after intravitreal vascular [corrected] endothelial growth factor antagonists: a six-year experience at a university referral center. Retina (2011) 2.97

Endophthalmitis isolates and antibiotic susceptibilities: a 10-year review of culture-proven cases. Am J Ophthalmol (2013) 2.90

Three-year follow-up of a randomized trial comparing focal/grid photocoagulation and intravitreal triamcinolone for diabetic macular edema. Arch Ophthalmol (2009) 2.84

Acute-onset endophthalmitis after cataract surgery (2000-2004): incidence, clinical settings, and visual acuity outcomes after treatment. Am J Ophthalmol (2005) 2.66

Reproducibility of macular thickness and volume using Zeiss optical coherence tomography in patients with diabetic macular edema. Ophthalmology (2007) 2.58

Oct-based interpretation of the vitreomacular interface and indications for pharmacologic vitreolysis. Retina (2013) 2.49

Infectious keratitis progressing to endophthalmitis: a 15-year study of microbiology, associated factors, and clinical outcomes. Ophthalmology (2012) 2.41

Characterization of birdshot chorioretinopathy using extramacular enhanced depth optical coherence tomography. JAMA Ophthalmol (2013) 2.36

The International Vitreomacular Traction Study Group classification of vitreomacular adhesion, traction, and macular hole. Ophthalmology (2013) 2.35

Signal strength is an important determinant of accuracy of nerve fiber layer thickness measurement by optical coherence tomography. J Glaucoma (2009) 2.19

Determination of vitreous, aqueous, and plasma concentration of orally administered voriconazole in humans. Arch Ophthalmol (2004) 2.15

Selective antimicrobial action is provided by phenol-soluble modulins derived from Staphylococcus epidermidis, a normal resident of the skin. J Invest Dermatol (2010) 2.13

Retained lens fragments after cataract surgery: outcomes of same-day versus later pars plana vitrectomy. Am J Ophthalmol (2013) 2.13

Pars plana vitrectomy for vitreous floaters: is there such a thing as minimally invasive vitreoretinal surgery? Retina (2014) 2.11

Visual and anatomical outcomes of macular epiretinal membrane peeling after previous rhegmatogenous retinal detachment repair. Retina (2015) 1.98

Endogenous fungal endophthalmitis: causative organisms, management strategies, and visual acuity outcomes. Am J Ophthalmol (2011) 1.92

Pathogenesis of macular holes and therapeutic implications. Am J Ophthalmol (2004) 1.91

Factors associated with variability in retinal nerve fiber layer thickness measurements obtained by optical coherence tomography. Ophthalmology (2007) 1.91

Endophthalmitis caused by Streptococcus pneumoniae. Am J Ophthalmol (2004) 1.91

Short-term outcomes of 23-gauge pars plana vitrectomy. Am J Ophthalmol (2008) 1.89

Factors associated with reduced visual acuity during long-term follow-up of patients with idiopathic central serous chorioretinopathy. Retina (2002) 1.86

Delayed- versus acute-onset endophthalmitis after cataract surgery. Am J Ophthalmol (2011) 1.83

Nosocomial acute-onset postoperative endophthalmitis at a university teaching hospital (2002-2009). Am J Ophthalmol (2010) 1.82

Acute-onset endophthalmitis after clear corneal cataract surgery (1996-2005). Clinical features, causative organisms, and visual acuity outcomes. Ophthalmology (2007) 1.79

Pars plana vitrectomy with internal limiting membrane peeling for diabetic macular edema. Retina (2008) 1.75

Culture-proven endogenous endophthalmitis: clinical features and visual acuity outcomes. Am J Ophthalmol (2004) 1.74

Area of peripheral retinal nonperfusion and treatment response in branch and central retinal vein occlusion. Retina (2014) 1.70

Acute macular neuroretinopathy: long-term insights revealed by multimodal imaging. Retina (2012) 1.68

Clinical characteristics in 53 patients with cat scratch optic neuropathy. Ophthalmology (2011) 1.62

Optical coherence tomography measurements and analysis methods in optical coherence tomography studies of diabetic macular edema. Ophthalmology (2008) 1.60

ENDOPHTHALMITIS CAUSED BY PSEUDOMONAS AERUGINOSA: Clinical Features, Antibiotic Susceptibilities, and Treatment Outcomes. Retina (2015) 1.58

Endophthalmitis after 25-gauge and 20-gauge pars plana vitrectomy: incidence and outcomes. Retina (2008) 1.57

Photoreceptor inner/outer segment defect imaging by spectral domain OCT and visual prognosis after macular hole surgery. Invest Ophthalmol Vis Sci (2009) 1.54

Exogenous fungal endophthalmitis: microbiology and clinical outcomes. Ophthalmology (2008) 1.51

Bariatric embolization for suppression of the hunger hormone ghrelin in a porcine model. Radiology (2012) 1.49

Clinical comparison of the Proview eye pressure monitor with the Goldmann applanation tonometer and the Tonopen. Arch Ophthalmol (2004) 1.48

Staphylococcus aureus endophthalmitis: antibiotic susceptibilities, methicillin resistance, and clinical outcomes. Am J Ophthalmol (2009) 1.48

Evaluation of age-related macular degeneration with optical coherence tomography. Surv Ophthalmol (2012) 1.47

Anti-vascular endothelial growth factor pharmacotherapy for age-related macular degeneration: a report by the American Academy of Ophthalmology. Ophthalmology (2008) 1.47

Factors associated with changes in visual acuity and central subfield thickness at 1 year after treatment for diabetic macular edema with ranibizumab. Arch Ophthalmol (2012) 1.47

An outbreak of streptococcus endophthalmitis after intravitreal injection of bevacizumab. Am J Ophthalmol (2012) 1.45

Endophthalmitis caused by Mycobacterium chelonae: selection of antibiotics and outcomes of treatment. Arch Ophthalmol (2003) 1.44

A randomized trial comparing intravitreal triamcinolone and focal/grid photocoagulation for diabetic macular edema: baseline features. Retina (2008) 1.43

Reducing the risk of endophthalmitis following intravitreal injections. Retina (2007) 1.39

SD OCT features of dry arcuate longstanding retinal folds. Eur J Ophthalmol (2011) 1.38

Spectral-domain optical coherence tomography appearance of preretinal aggregation of intravitreal antibiotics. Retina (2010) 1.38

Relationship between optical coherence tomography retinal parameters and visual acuity in diabetic macular edema. Ophthalmology (2010) 1.38

Evaluation of optical coherence tomography retinal thickness parameters for use in clinical trials for neovascular age-related macular degeneration. Invest Ophthalmol Vis Sci (2009) 1.36

Endophthalmitis caused by Pseudomonas aeruginosa. Ophthalmology (2003) 1.36

Incidence of endophthalmitis after 20-gauge vs 23-gauge vs 25-gauge pars plana vitrectomy. Graefes Arch Clin Exp Ophthalmol (2010) 1.33

Sympathetic ophthalmia: incidence of ocular complications and vision loss in the sympathizing eye. Am J Ophthalmol (2009) 1.33

Quantitative subanalysis of optical coherence tomography after treatment with ranibizumab for neovascular age-related macular degeneration. Invest Ophthalmol Vis Sci (2008) 1.33

Cellular senescence in the glaucomatous outflow pathway. Exp Gerontol (2005) 1.32

Open globe injuries with positive intraocular cultures: factors influencing final visual acuity outcomes. Ophthalmology (2003) 1.29

Spatial distribution of posterior pole choroidal thickness by spectral domain optical coherence tomography. Invest Ophthalmol Vis Sci (2011) 1.28

Macular pucker removal with and without internal limiting membrane peeling: pilot study. Ophthalmology (2003) 1.26

Trends in the indications for penetrating keratoplasty, 1980-2001. Cornea (2005) 1.25

Relationship among visual field, blood flow, and neural structure measurements in glaucoma. Invest Ophthalmol Vis Sci (2012) 1.25

Effects of tryptophan microenvironment, soluble domain, and vesicle size on the thermodynamics of membrane protein folding: lessons from the transmembrane protein OmpA. Biochemistry (2008) 1.23

Marking embryonic stem cells with a 2A self-cleaving peptide: a NKX2-5 emerald GFP BAC reporter. PLoS One (2008) 1.22

Endophthalmitis caused by enterococcus faecalis: antibiotic selection and treatment outcomes. Ophthalmology (2003) 1.21

Vibrational Relaxation in beta-Carotene Probed by Picosecond Stokes and Anti-Stokes Resonance Raman Spectroscopy. J Phys Chem A (2002) 1.21

Delayed-onset bleb-associated endophthalmitis (1996-2008): causative organisms and visual acuity outcomes. Retina (2011) 1.20

Update on retinal detachment surgery. Curr Opin Ophthalmol (2013) 1.19

Delayed-onset bleb-associated endophthalmitis: clinical features and visual acuity outcomes. Ophthalmology (2002) 1.18

Anti-VEGF Treatment Strategies for Wet AMD. J Ophthalmol (2012) 1.17

Staphylococcus epidermidis antimicrobial delta-toxin (phenol-soluble modulin-gamma) cooperates with host antimicrobial peptides to kill group A Streptococcus. PLoS One (2010) 1.17

Resonance Raman studies of the (His)(Cys)3 2Fe-2S cluster of MitoNEET: comparison to the (Cys)4 mutant and implications of the effects of pH on the labile metal center. Biochemistry (2009) 1.17

Relationship between optical coherence tomography retinal parameters and visual acuity in neovascular age-related macular degeneration. Ophthalmology (2008) 1.15

Comparison of clinically relevant findings from high-speed fourier-domain and conventional time-domain optical coherence tomography. Am J Ophthalmol (2009) 1.15

Intravitreal injection technique and monitoring: updated guidelines of an expert panel. Retina (2014) 1.15

Effects on the contralateral eye after intravitreal bevacizumab and ranibizumab injections: a case report. Ann Acad Med Singapore (2008) 1.15

Intravitreal injection analysis at the Bascom Palmer Eye Institute: evaluation of clinical indications for the treatment and incidence rates of endophthalmitis. Clin Ophthalmol (2010) 1.14

Endophthalmitis after pars plana vitrectomy: Incidence, causative organisms, and visual acuity outcomes. Am J Ophthalmol (2004) 1.12

Persistent outer retinal defect after successful macular hole repair. Am J Ophthalmol (2005) 1.12

Body mass index has a linear relationship with cerebrospinal fluid pressure. Invest Ophthalmol Vis Sci (2012) 1.11

Outcomes of surgery for retinal detachment associated with proliferative vitreoretinopathy using perfluoro-n-octane: a multicenter study. Am J Ophthalmol (2003) 1.11

In vitro fluoroquinolone resistance in staphylococcal endophthalmitis isolates. Arch Ophthalmol (2006) 1.11

Vision-related quality of life in persons with unilateral branch retinal vein occlusion using the 25-item National Eye Institute Visual Function Questionnaire. Br J Ophthalmol (2009) 1.10

Retinal and optic nerve diseases. Artif Organs (2003) 1.10

Combined ceftazidime and amikacin resistance among Gram-negative isolates in acute-onset postoperative endophthalmitis: prevalence, antimicrobial susceptibilities, and visual acuity outcome. J Ophthalmic Inflamm Infect (2013) 1.09

Comparison of intravitreal bevacizumab followed by ranibizumab for the treatment of neovascular age-related macular degeneration. Retina (2009) 1.09

Documentation by spectral domain OCT of spontaneous closure of idiopathic macular holes. Ophthalmic Surg Lasers Imaging (2007) 1.09

In vivo imaging of retinal pigment epithelium cells in age related macular degeneration. Biomed Opt Express (2013) 1.09

Evolving strategies in the management of diabetic macular edema: clinical trials and current management. Can J Ophthalmol (2013) 1.08

Endophthalmitis caused by Moraxella osloensis. Graefes Arch Clin Exp Ophthalmol (2002) 1.08

Long-term anatomic and visual acuity outcomes after initial anatomic success with macular hole surgery. Am J Ophthalmol (2003) 1.08

Toll-like receptor 2 ligand-induced protection against bacterial endophthalmitis. J Infect Dis (2010) 1.07

Management of intraocular foreign bodies: a clinical flight plan. Can J Ophthalmol (2013) 1.06

Prevalence and risk factors for proliferative vitreoretinopathy in eyes with rhegmatogenous retinal detachment but no previous vitreoretinal surgery. Am J Ophthalmol (2004) 1.06

Three-dimensional distribution of the vitelliform lesion, photoreceptors, and retinal pigment epithelium in the macula of patients with best vitelliform macular dystrophy. Arch Ophthalmol (2011) 1.06

Clinical features and outcomes of pars plana vitrectomy in patients with retained lens fragments. Ophthalmology (2003) 1.06